Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

PMEA 2021 has officially launched – with a new online entry system

New ‘Response to the COVID-19 Pandemic Crisis’ category introduced for this year’s awards

How Patient Advocacy Can Positively Disrupt Healthcare

Seth Rotberg, Patient Recruitment Manager at WEGO Health & Co-Founder of Our Odyssey, shares his views on how to empower rare disease patients, improve clinical trials, and move towards a...

Impetus Digital

Leaders in Pharma: Danielle Portnik

In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Danielle Portnik. She is currently the Regional Business Director for International with Ambry Genetics.

Impetus Digital

GIG Opinions - Your brand is more than a logo.

You Brand Is More Than A Logo

Jon discusses how a good logo alone does not complete the brand, especially today when that brand has to adapt and live across many channels.

The Good Ideas Group

- PMLiVE

Healthware Group appoints Yannick Valenti as digital strategy and customer engagement director

Prior to Healthware, Valenti spent three years at Ogilvy Health as digital strategy director

- PMLiVE

Lucid Group promotes Clare Reynolds to newly created role

Reynolds initially joined Lucid in 2009 as business unit director

- PMLiVE

Corin Baird joins Havas Just:: as head of digital

Baird joins the team with a varied background in digital marketing

- PMLiVE

Strategy experts: the real thing

What defines genuine strategy experts in the biomedical industry?

- PMLiVE

Versiti launches test for vaccine-related blood clot issues

Launch follows reports of very rare blood clots connected to J&J's vaccine

- PMLiVE

Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics

Drug could treat life-threatening antifungal-resistant infections

- PMLiVE

GSK’s revenue drops by 18% in Q1 as performance pressures mount

Chief executive Emma Walmsley said results ‘reflect the anticipated impacts of COVID-19’

- PMLiVE

Novartis announces delay in UK cholesterol drug study

The delay was caused by recruitment issues during the COVID-19 pandemic

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links